GO:0097418 neurofibrillary tangle: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0097418 neurofibrillary tangle is a cellular_component defined as an intracellular mass of paired, helically wound filaments (PHF) in neuronal cytoplasm, composed of abnormally phosphorylated tau.
• Neurofibrillary tangles (NFTs) are a hallmark of Alzheimer's disease and other tauopathies, and their maturity can be staged by immunophenotype signatures.
• Tangle-bearing neurons show reduced risk of cell death in mouse models, suggesting a complex relationship between tangles and neurodegeneration.
• Single-nucleus transcriptomics has revealed molecular signatures underlying tangle susceptibility, highlighting genes and pathways that distinguish vulnerable neurons.
• Exercise and anti-amyloid/tau strategies are being explored to suppress neuroinflammation and tangle formation in Alzheimer's disease models.
• Research on NFTs employs knockout, knock-in, and overexpression models, combined with imaging, proteomics, and CRISPR screening to dissect tau pathology.
Description
Neurofibrillary tangles (NFTs) are intracellular inclusions that define a class of neurodegenerative disorders known as tauopathies, with Alzheimer's disease (AD) being the most prevalent. The term GO:0097418 neurofibrillary tangle describes a cellular_component characterized by paired, helically wound filaments (PHF) that accumulate in the cytoplasm of neuronal cell bodies and neuritic processes. These structures contain an abnormally phosphorylated form of the microtubule-associated protein tau, and their shape can resemble a flame or a star. Understanding the biology of NFTs is critical because their presence correlates with cognitive decline and disease progression in AD and related disorders. Researchers study NFTs to uncover mechanisms of tau aggregation, neuronal vulnerability, and potential therapeutic targets.
neurofibrillary tangle At A Glance
| GO ID | GO:0097418 |
|---|---|
| GO term | neurofibrillary tangle |
| Ontology | cellular_component |
| Synonym | flame-shaped neurofibrillary tangle, star-shaped neurofibrillary tangle |
| Major function | Intracellular accumulation of paired helical filaments composed of hyperphosphorylated tau; hallmark of tauopathies |
| Definition | Intracellular mass of paired, helically wound protein filaments (PHF) in neuronal cytoplasm, containing abnormally phosphorylated tau |
| Related disease | Alzheimer's disease, frontotemporal dementia, progressive supranuclear palsy, corticobasal degeneration |
| Key protein | Microtubule-associated protein tau (MAPT) |
| Research methods | Immunohistochemistry, single-nucleus RNA-seq, proteomics, CRISPR screening, imaging |
What Is GO:0097418?
The neurofibrillary tangle (GO:0097418) is an intracellular mass of paired, helically wound protein filaments (PHF) located in the cytoplasm of neuronal cell bodies and neuritic cell processes. It contains an abnormally phosphorylated form of the microtubule-associated protein tau. The inclusion may appear flame-shaped or star-shaped. This definition is based on the QuickGO ontology entry for GO:0097418.
Why Is neurofibrillary tangle Important in Cell Biology?
Neurofibrillary tangles are a central pathological feature of Alzheimer's disease and other tauopathies, and their density and distribution correlate with cognitive impairment. The presence of NFTs distinguishes AD from other dementias and serves as a diagnostic and staging biomarker. Understanding the molecular mechanisms of tangle formation, maturation, and neuronal toxicity is essential for developing disease-modifying therapies. Moreover, tangle-bearing neurons may exhibit reduced cell death in some models, indicating that tangles themselves might not be directly toxic, which complicates therapeutic strategies.
• NFTs are a hallmark lesion of Alzheimer's disease and correlate with cognitive decline.
• Tangle maturity can be staged using immunophenotype signatures, aiding in disease classification.
• Tau pathology is implicated in a spectrum of neurodegenerative disorders beyond AD, including frontotemporal dementia and parkinsonian disorders.
• Single-nucleus transcriptomics has identified molecular signatures of tangle susceptibility, revealing vulnerable neuronal populations.
• Tangle-bearing neurons may have reduced risk of cell death in mouse models, challenging the assumption that tangles are directly toxic.
• Exercise and anti-inflammatory interventions may alleviate AD pathology, including tangle formation, in preclinical models.
• Inhibition of amyloid beta and tau tangle formation is a major therapeutic strategy.
• Senile dementia of the neurofibrillary tangle type (SD-NFT) is a distinct entity characterized by abundant NFTs without amyloid plaques.
• NFTs are composed of hyperphosphorylated tau, making tau phosphorylation a key research focus.
• CRISPR-based models enable functional dissection of genes involved in tau aggregation and tangle formation.
Structure and Composition of neurofibrillary tangle
Tau protein and its normal function
In simple terms: Tau is a protein that normally helps stabilize microtubules in neurons.
Tau (encoded by MAPT) is a microtubule-associated protein that promotes microtubule assembly and stability in axons. In its normal state, tau is soluble and loosely bound to microtubules. However, in tauopathies, tau undergoes abnormal phosphorylation and conformational changes that lead to its detachment from microtubules and aggregation into paired helical filaments (PHF).
Hyperphosphorylation and conformational change
In simple terms: When tau gets too many phosphate groups, it changes shape and starts sticking together.
Abnormal phosphorylation of tau at specific serine and threonine residues is a key event in NFT formation. This hyperphosphorylation reduces tau's affinity for microtubules and promotes its self-assembly into PHF. Conformational changes expose regions that facilitate aggregation and filament formation.
Paired helical filament (PHF) assembly
In simple terms: Tau molecules twist together into rope-like structures called paired helical filaments.
PHFs are the major structural component of NFTs. They consist of two filaments wound around each other in a helical fashion. The assembly of PHFs involves the stacking of tau molecules in a beta-sheet-rich conformation. Cryo-EM studies have revealed the atomic structure of PHFs in AD, showing a specific fold of the tau repeat domain.
Tangle maturation and morphology
In simple terms: Tangles go through different stages as they grow and change shape.
NFTs mature over time, and their immunophenotype changes with maturity. Early tangles are often flame-shaped and contain full-length tau, while mature tangles may be star-shaped and contain truncated tau. Antibodies against different phospho-tau epitopes can distinguish these stages, providing a clinicopathologic framework for biomarker research.
Cellular consequences of tangles
In simple terms: Tangles can disrupt neuron function, but they may also protect against cell death in some cases.
The presence of NFTs disrupts microtubule stability, axonal transport, and synaptic function. However, recent studies in mouse models show that tangle-bearing neurons have reduced risk of cell death, suggesting a complex relationship between tangles and neurodegeneration. Single-nucleus transcriptomics has identified molecular signatures that distinguish tangle-bearing neurons from unaffected ones, highlighting genes involved in stress responses and survival.
Key Genes Involved in GO:0097418 neurofibrillary tangle
The following genes and proteins are central to the biology of neurofibrillary tangles, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAPT | Encodes tau; mutations cause familial tauopathies | Primary gene for NFT formation; target for knock-in and knockout models |
| GSK3B | Phosphorylates tau; promotes tangle formation | Kinase target; inhibition reduces tau phosphorylation |
| CDK5 | Phosphorylates tau at specific sites | Involved in tau hyperphosphorylation; knockout models show reduced pathology |
| PPP1CA | Protein phosphatase 1; dephosphorylates tau | Regulates tau phosphorylation balance; overexpression reduces tangles |
| PIN1 | Peptidyl-prolyl isomerase; regulates tau conformation | Modulates tau aggregation; knockout increases tangle formation |
| APOE | Lipid transport; risk factor for AD | Isoform-specific effects on tangle burden; knock-in models |
| BIN1 | Endocytosis and tau propagation | GWAS risk gene; knockout reduces tau spread |
| CLU | Chaperone; involved in amyloid and tau pathology | Risk gene; overexpression models |
| PICALM | Endocytosis; modulates tau clearance | Risk gene; knockout affects tangle formation |
| TREM2 | Microglial receptor; inflammation | Risk gene; knockout alters tau pathology |
| CD33 | Microglial inhibition | Risk gene; knockout enhances tau clearance |
| CR1 | Complement receptor; inflammation | Risk gene; knockout models |
| ABCA7 | Lipid transport; microglial function | Risk gene; knockout affects tau pathology |
| SORL1 | Endosomal sorting; tau processing | Risk gene; knockout models |
| FYN | Kinase; interacts with tau | Regulates tau phosphorylation; knockout reduces pathology |
| MARK4 | Kinase; phosphorylates tau | Overexpression increases tau phosphorylation |
| TP53 | Tumor suppressor; stress response | Linked to tau-induced neurodegeneration; knockout models |
| CASP3 | Apoptosis executioner; cleaves tau | Generates truncated tau; knockout reduces tangle formation |
How Is neurofibrillary tangle Regulated?
Neurofibrillary tangle formation is regulated by a balance of kinases and phosphatases that control tau phosphorylation. GSK3B and CDK5 are major kinases that phosphorylate tau, while PPP1CA and PPP2CA are phosphatases that dephosphorylate it. The peptidyl-prolyl isomerase PIN1 regulates tau conformation and can either promote or inhibit aggregation depending on context. Additionally, cellular stress pathways such as the unfolded protein response and autophagy-lysosomal pathways influence tau clearance and aggregation. Inflammatory signaling via microglia, involving TREM2 and CD33, also modulates tau pathology.
neurofibrillary tangle and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MAPT | Alzheimer's disease, FTDP-17, tauopathies | Knock-in of human mutant tau; knockout of endogenous tau |
| APOE | Alzheimer's disease risk | Knock-in of human APOE isoforms (e2, e3, e4) |
| TREM2 | Alzheimer's disease risk, microglial function | Knockout and knock-in of R47H variant |
| GSK3B | Tau hyperphosphorylation | Knockout or overexpression to modulate tau phosphorylation |
| CASP3 | Tau truncation and tangle formation | Knockout to prevent tau cleavage |
Alzheimer's disease
Alzheimer's disease is the most common tauopathy, characterized by both amyloid-beta plaques and neurofibrillary tangles. NFT density correlates with cognitive decline, and tangle maturity staging is used in clinicopathologic diagnosis. Single-nucleus transcriptomics has revealed that tangle-bearing neurons exhibit distinct molecular signatures, including upregulation of stress response genes and downregulation of synaptic genes. Mouse models show that tangle-bearing neurons may have reduced cell death, suggesting a protective role for tangles in some contexts.
Frontotemporal dementia and parkinsonian disorders
Mutations in MAPT cause frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17), which is characterized by tau-positive inclusions. Neurofibrillary tangle parkinsonian disorders, such as progressive supranuclear palsy and corticobasal degeneration, also feature tau pathology with distinct filament structures. These disorders highlight the clinical heterogeneity of tauopathies and the importance of tau genetics.
Senile dementia of the neurofibrillary tangle type (SD-NFT)
SD-NFT is a distinct form of dementia characterized by abundant NFTs in the absence of amyloid plaques, predominantly in the limbic system. It is more common in the elderly and can be misdiagnosed as Alzheimer's disease. The study of SD-NFT provides insights into the role of tau pathology independent of amyloid.
From neurofibrillary tangle-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MAPT prevent tangle formation? | MAPT knockout mice or human iPSC-derived neurons |
| How does mutant tau cause familial tauopathy? | Knock-in of human MAPT mutations (e.g., P301L, V337M) |
| What is the role of tau phosphorylation at specific sites? | Point mutations at serine/threonine residues (e.g., S396A, S404A) |
| Can we track tau aggregation in live cells? | Tagged knock-in of fluorescent tau (e.g., GFP-tau) |
| Does overexpression of tau recapitulate tangle pathology? | Transgenic overexpression of human tau in mice or cell lines |
| Which genes modify tangle susceptibility? | CRISPR library screening in iPSC-derived neurons |
How to Study the neurofibrillary tangle Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Immunohistochemistry | Presence and distribution of NFTs | Post-mortem brain staging |
| Single-nucleus RNA-seq | Transcriptomic profiles of tangle-bearing neurons | Identifying susceptibility genes |
| Phosphoproteomics | Tau phosphorylation sites and signaling | Kinase/phosphatase discovery |
| Cryo-EM | Atomic structure of PHFs | Understanding tau filament folds |
| Live-cell imaging | Tau aggregation dynamics | Screening for aggregation inhibitors |
| CRISPR knockout screening | Genes affecting tangle formation | Functional genomics |
| ELISA | Total and phospho-tau levels | Biomarker development |
| Behavioral tests | Cognitive function in mouse models | Assessing tangle-induced deficits |
Immunohistochemistry and imaging
Immunohistochemistry using phospho-tau-specific antibodies (e.g., AT8, PHF1) is the gold standard for detecting NFTs in brain tissue. Advanced imaging techniques such as super-resolution microscopy and cryo-electron tomography reveal the ultrastructure of PHFs. In live cells, fluorescently tagged tau allows tracking of aggregation dynamics.
Transcriptomics and single-nucleus RNA-seq
Single-nucleus RNA-seq has been used to profile tangle-bearing neurons and identify molecular signatures of susceptibility. This approach reveals gene expression changes associated with tangle formation and neuronal vulnerability, providing insights into disease mechanisms.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can quantify tau phosphorylation sites and identify interacting proteins in NFTs. Phosphoproteomics reveals the kinase/phosphatase landscape that regulates tau aggregation.
CRISPR screening and functional genomics
CRISPR knockout and activation screens in cell models can identify genes that modify tau aggregation and tangle formation. These screens are valuable for discovering novel therapeutic targets and understanding the genetic basis of tangle susceptibility.
How CRISPR Can Be Used to Study GO:0097418 neurofibrillary tangle
Knockout
CRISPR knockout of MAPT eliminates tau expression and prevents tangle formation in cellular and animal models. Knockout of kinases such as GSK3B or CDK5 reduces tau hyperphosphorylation and tangle burden. Knockout of risk genes like TREM2 or APOE alters tau pathology in mouse models.
Point Mutation
Point mutations in MAPT (e.g., P301L, S396A) can be introduced using CRISPR to model familial tauopathies or to study the role of specific phosphorylation sites. These models help dissect the contribution of individual residues to tau aggregation and toxicity.
Knock-in
Knock-in of human mutant MAPT or risk variants (e.g., APOE4, TREM2 R47H) into mouse or human cells creates physiologically relevant models of tau pathology. Tagged knock-in of fluorescent tau allows real-time visualization of aggregation.
Overexpression
Overexpression of human tau or mutant tau in cell lines and transgenic mice recapitulates key features of tauopathy, including NFT formation and neuronal loss. Overexpression of kinases like MARK4 increases tau phosphorylation and aggregation.
How EDITGENE Supports neurofibrillary tangle Research
Researchers studying neurofibrillary tangle-related genes often need to determine whether a candidate gene is causally involved in tau aggregation, tangle formation, or neuronal toxicity. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for neurofibrillary tangle research.
Frequently Asked Questions About neurofibrillary tangle
What is a neurofibrillary tangle?
A neurofibrillary tangle (GO:0097418) is an intracellular mass of paired helical filaments composed of hyperphosphorylated tau protein, found in neurons of patients with Alzheimer's disease and other tauopathies.
What genes are involved in neurofibrillary tangles?
Key genes include MAPT (tau), GSK3B, CDK5, APOE, TREM2, and BIN1, among others.
What is the difference between neurofibrillary tangles and amyloid plaques?
Neurofibrillary tangles are intracellular aggregates of tau, while amyloid plaques are extracellular deposits of amyloid-beta. Both are hallmarks of Alzheimer's disease.
How are neurofibrillary tangles detected?
They are detected by immunohistochemistry using phospho-tau antibodies (e.g., AT8, PHF1) and by advanced imaging techniques.
What diseases are associated with neurofibrillary tangles?
Alzheimer's disease, frontotemporal dementia, progressive supranuclear palsy, corticobasal degeneration, and senile dementia of the neurofibrillary tangle type.
Can neurofibrillary tangles be reversed?
Current research aims to prevent or reduce tangle formation through kinase inhibitors, immunotherapy, and gene editing, but reversal remains challenging.
What is the role of tau phosphorylation in tangle formation?
Hyperphosphorylation of tau causes it to detach from microtubules and aggregate into paired helical filaments, the main component of tangles.
How do CRISPR models help study neurofibrillary tangles?
CRISPR knockout, knock-in, and point mutation models allow researchers to dissect the function of tau and related genes in tangle formation and neuronal toxicity.
What is the maturity of neurofibrillary tangles?
Tangle maturity refers to stages of tangle development, from early flame-shaped to mature star-shaped, which can be classified by immunophenotype signatures.
Are neurofibrillary tangles toxic to neurons?
Recent studies suggest that tangle-bearing neurons may have reduced risk of cell death in mouse models, indicating a complex relationship between tangles and neurotoxicity.
Conclusion
Neurofibrillary tangles (GO:0097418) are a defining pathological feature of Alzheimer's disease and related tauopathies, composed of hyperphosphorylated tau assembled into paired helical filaments. Their presence correlates with cognitive decline, and their maturity can be staged using immunophenotypic markers. Understanding the molecular mechanisms of tangle formation, regulation, and neuronal impact is essential for developing effective therapies. CRISPR-based models and advanced omics technologies are powerful tools to dissect the genetic and molecular underpinnings of tangle biology, offering hope for new therapeutic strategies.
References
- 1. Otero-Garcia M et al.. 2022. Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer's disease.. Neuron 110(18):2929-2948.e8 PMID: 35882228
- 2. Zwang TJ et al.. 2024. Neurofibrillary tangle-bearing neurons have reduced risk of cell death in mice with Alzheimer's pathology.. Cell Rep 43(8):114574 PMID: 39096489
- 3. Moloney CM et al.. 2021. Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research.. Alzheimers Dement 17(9):1554-1574 PMID: 33797838
- 4. Hamlin D et al.. 2024. Characterization of neurofibrillary tangle immunophenotype signatures to classify tangle maturity in Alzheimer's disease.. Alzheimers Dement 20(7):4803-4817 PMID: 38884346
- 5. Wang M et al.. 2023. Exercise suppresses neuroinflammation for alleviating Alzheimer's disease.. J Neuroinflammation 20(1):76 PMID: 36935511
- 6. Ashrafian H et al.. 2021. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.. Int J Biol Macromol 167:382-394 PMID: 33278431
- 7. Yamada M. 2018. [Senile Dementia of the Neurofibrillary Tangle Type (SD-NFT)].. Brain Nerve 70(5):533-541 PMID: 29760290
- 8. Morris HR et al.. 1999. Neurofibrillary tangle parkinsonian disorders--tau pathology and tau genetics.. Mov Disord 14(5):731-6 PMID: 10495033
